← Back to Search

Photoacoustic Imaging for Soft Tissue Sarcoma

N/A
Waitlist Available
Led By Anurag Singh
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Study Summary

This trial is testing how well a new low-risk imaging method, photoacoustic imaging, works in diagnosing changes in tumors in participants with breast cancer, sarcoma, skin cancer, or soft tissue malignancy and healthy volunteers.

Eligible Conditions
  • Soft Tissue Sarcoma
  • Healthy Subjects
  • Sarcoma
  • Skin Cancer
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of photoacoustic imaging (PAI) to quantify tumor characteristics
Secondary outcome measures
Hyperbaric oxygenation therapy
Utility of serial PAI measurements

Trial Design

1Treatment groups
Experimental Treatment
Group I: Diagnostic (photoacoustic imaging)Experimental Treatment1 Intervention
Participants undergo PAI on different parts of the body over 20 minutes for up to 5 imaging sessions for 6 months.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,717 Previous Clinical Trials
40,953,357 Total Patients Enrolled
Roswell Park Cancer InstituteLead Sponsor
404 Previous Clinical Trials
31,294 Total Patients Enrolled
Anurag SinghPrincipal InvestigatorRoswell Park Cancer Institute
9 Previous Clinical Trials
209 Total Patients Enrolled
~1 spots leftby May 2025